Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

Terwilliger, E. F. et al. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl Acad. Sci. USA 86, 5163–5167 (1989)

Strebel, K. et al. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 63, 3784–3791 (1989)

Klimkait, T. et al. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64, 621–629 (1990)

Gottlinger, H. G. et al. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl Acad. Sci. USA 90, 7381–7385 (1993)

Geraghty, R. J. et al. Cell type-dependence for Vpu function. J. Med. Primatol. 23, 146–150 (1994)

Neil, S. J. et al. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog. 2, e39 (2006)

Varthakavi, V. et al. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc. Natl Acad. Sci. USA 100, 15154–15159 (2003)

Neil, S. J. et al. An interferon-α-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2, 193–203 (2007)

Harila, K. et al. Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag. J. Virol. 80, 3765–3772 (2006)

Harila, K. et al. The Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent. Virology 369, 299–308 (2007)

Ishikawa, J. et al. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 26, 527–534 (1995)

Willey, R. L. et al. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193–7200 (1992)

Ross, T. M., Oran, A. E. & Cullen, B. R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9, 613–621 (1999)

Lama, J., Mangasarian, A. & Trono, D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9, 622–631 (1999)

Kupzig, S. et al. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4, 694–709 (2003)

Rollason, R. et al. Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J. Cell Sci. 120, 3850–3858 (2007)

Jouvenet, N. et al. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4, e435 (2006)

Muller, B. et al. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 78, 10803–10813 (2004)

Goto, T. et al. A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 84, 1922–1930 (1994)

Blasius, A. L. et al. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177, 3260–3265 (2006)

Brugger, B. et al. The HIV lipidome: a raft with an unusual composition. Proc. Natl Acad. Sci. USA 103, 2641–2646 (2006)

Bartee, E., McCormack, A. & Fruh, K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2, e107 (2006)